Pharmaceutical IP and competition law in South Africa: overview

Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie

A Q&A guide to pharmaceutical IP and competition law in South Africa.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

To read the full Q&A, visit Thomson Reuters Practical Law.

For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.

Alexis Apostolidis
Partner | Head of Competition Law Group
Danie-Dohmen-author
Danie Dohmen
Partner | Patent Attorney
Jenny Pienaar
Partner | Trade Mark Attorney
View Related Blogs
View All
news

Chat Chat Chatterbot - Shall We Register Your Name?

So, you have birthed a chatbot and given it a name, what now? Should you register the name of the chatbot as a trade mark? The answer is a simple one, yes. If the chatbots are customer-facing, particu...

Alissa Naran (née Nayanah)BrandingIntellectual PropertyTrade Marks
news

Tacos, trade marks and the CHINGADA’S question: The curious case of a Cape Town restaurant name

I went to Chingada’s in Cape Town this week for Taco Tuesday. It is a striking restaurant: colourful, theatrical and deliberately Mexican in its presentation. As tends to happen when one encounters ...

Bontle MonnyaBrandingIntellectual PropertyTrade Marks
news

Your Brand Crossed the Border. Did Your Trade Mark?

Why foreign brand owners should protect their trade marks in South Africa By Amina Suliman and Ntethelelo Ndaba Your Brand Is Here. Are Your Rights? Expanding into a new market is exciting. Businesses...

Amina SulimanIntellectual PropertyTrade Marks